« Previous Next » Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 1 , Pages 75-80 , January 2008

Therapeutic Use of Botulinum Toxin Type A in Treating Neck and Upper-Back Pain of Myofascial Origin: A Pilot Study

Presented as a poster to the American Academy of Physical Medicine and Rehabilitation, November 2006, Honolulu, HI.

Flow of participants in the study.

Flow of participants in the study.
- Full-Size Image
- Download to PowerPoint
Mean changes in pain scores on the VAS from baseline (BTX-A vs control). Negative change indicates improved outcome.

Mean changes in pain scores on the VAS from baseline (BTX-A vs control). Negative change indicates improved outcome.
- Full-Size Image
- Download to PowerPoint
Improvement in mean scores on the SF-36 bodily pain scale from baseline (BTX-A vs control). *Statistically significantly better outcome for the BTX-A group (P<.025).

Improvement in mean scores on the SF-36 bodily pain scale from baseline (BTX-A vs control). *Statistically significantly better outcome for the BTX-A group (P<.025).
- Full-Size Image
- Download to PowerPoint
Improvement in mean scores on the SF-36 mental health scale from baseline (BTX-A vs control). *Statistically significantly better outcome for the BTX-A group (P<.025).

Improvement in mean scores on the SF-36 mental health scale from baseline (BTX-A vs control). *Statistically significantly better outcome for the BTX-A group (P<.025).
- Full-Size Image
- Download to PowerPoint

Supported in part by Allergan Inc.

No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.

PII: S0003-9993(07)01616-4

doi: 10.1016/j.apmr.2007.08.133

« Previous Next » Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 1 , Pages 75-80 , January 2008